What are the recommended dosages for stimulant and non-stimulant medications, such as methylphenidate (Ritalin) and atomoxetine (Strattera), for the treatment of Attention Deficit Hyperactivity Disorder (ADHD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dosages for ADHD Medications

For optimal treatment of ADHD, methylphenidate should be started at 5 mg twice daily for children and titrated weekly by 5-10 mg increments to a maximum of 60 mg daily, while atomoxetine should be initiated at 0.5 mg/kg/day and titrated to 1.2-1.8 mg/kg/day with a maximum of 100 mg daily. 1

Stimulant Medications

Methylphenidate (MPH)

Children and Adolescents (6+ years)

  • Starting dose: 5 mg twice daily (before breakfast and lunch) 1, 2
  • Titration: Increase by 5-10 mg weekly based on response and side effects 1
  • Maximum daily dose: 60 mg (not to exceed this amount regardless of formulation) 1, 2
  • Children weighing less than 25 kg should generally not receive single doses greater than 15 mg 1

Adults

  • Starting dose: 5-10 mg twice or three times daily 2
  • Average dosage: 20-30 mg daily 2
  • Maximum daily dose: 60 mg 2
  • Administration: Preferably 30-45 minutes before meals 2

Amphetamine Formulations

Children and Adolescents

  • Starting dose: 2.5 mg for dextroamphetamine/amphetamine 1
  • Maximum daily dose: 40 mg for amphetamines 1
  • For lisdexamfetamine: Titrate based on clinical response with maximum of 70 mg daily 1, 3

Adults

  • Maximum daily dose: 40 mg for dextroamphetamine/amphetamine 3
  • For lisdexamfetamine: Up to 70 mg daily 1

Non-Stimulant Medications

Atomoxetine

  • Starting dose: 0.5 mg/kg/day 1
  • Target dose: 1.2-1.8 mg/kg/day 1, 4
  • Maximum daily dose: 100 mg in Malaysia and India, 120 mg in Japan 1
  • Administration: Can be given as a single daily dose or split into two evenly divided doses 1, 5
  • Duration: Treatment effects typically observed after 6-12 weeks of treatment 1

Clonidine

  • Available dosages: 0.1 mg and 0.2 mg tablets 1
  • Starting dose: 0.1 mg tablet at bedtime 1
  • Titration: Increase to twice-daily administration with careful uptitration 1
  • Maximum daily dose: 0.4 mg 1
  • Duration: Treatment effects typically observed after 2-4 weeks 1

Guanfacine

  • Available dosages: 1,2,3, and 4 mg tablets 1
  • Dosing: Adjusted to body weight (approximately 0.1 mg/kg as a rule of thumb) 1
  • Maximum daily dose: 6 mg 1
  • Administration: Once-daily, preferably in the evening due to somnolence/fatigue side effects 1
  • Duration: Treatment effects typically observed after 2-4 weeks 1

Monitoring and Titration Guidelines

  • Titrate medication doses based on clinical response and presence of side effects 1, 3
  • Use standardized rating scales from parents and teachers for children, and self-reports for adults 3
  • Monitor vital signs including blood pressure, pulse, height, and weight at each visit 3, 2
  • During initial titration, maintain weekly contact (can be by telephone) 1
  • After stabilization, follow-up appointments should be at least monthly 1

Important Considerations

  • Individual response to medications varies significantly; some patients may require higher or lower doses 1, 6
  • Weight-adjusted dosing may not be reliable for all patients, as individual response varies 1
  • Non-stimulants generally have smaller effect sizes compared to stimulants and are often considered second-line treatments 1
  • Stimulants have a rapid onset of action (within hours), while non-stimulants take weeks to reach full effectiveness 1, 7
  • Common side effects of stimulants include decreased appetite, insomnia, and increased heart rate/blood pressure 1, 2
  • Common side effects of non-stimulants include somnolence, fatigue, and irritability for alpha-2 agonists (clonidine, guanfacine) 1

Regional Variations in Maximum Doses

  • Japan: OROS-MPH maximum 54 mg/day, atomoxetine maximum 120 mg/day 1
  • Malaysia: MPH-ER maximum 72 mg/day, atomoxetine maximum 100 mg/day 1
  • India: OROS-MPH maximum 72 mg/day, atomoxetine maximum 100 mg/day 1
  • Republic of Korea: OROS-MPH maximum 72 mg/day, atomoxetine maximum 1.4 mg/kg 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.